Source: United Press International
“In a finding that suggests Ozempic and Wegovy have powers that extend beyond weight loss, a new study finds the medications might also lower people’s risk of opioid overdose. People with Type 2 diabetes prescribed semaglutide (Ozempic, Wegovy) had a significantly lower risk of an opioid OD than patients taking any of eight other diabetic medications, researchers found. … For the study, researchers analyzed six years of medical data for nearly 33,000 patients with opioid use disorder who also had Type 2 diabetes.” (09/25/24)
https://www.upi.com/Health_News/2024/09/25/study-ozempic-lower-risk-opioid-overdose/9031727277798/